EHMSG gratefully acknowledges the support of the following companies and institutions
RICHEN EUROPE is the European operating branch of the RICHEN GROUP, a major international group of medical device manufacturers with a global commitment. The company specializes in developing the best solutions for patients in the field of gastroenterology. Over the years our R&D department has excelled in the design and development of high-performance safe equipment and reagents for the diagnosis of Helicobacter pylori infection. Since 2015, the Richen Group has been supporting the European Helicobacter & Microbiota Study Group (EHMSG) as Platinum Sponsor.
INFAI is specialized in the transfer of advanced analytical technology in the field of medical diagnostics and the development of innovative pharmaceutical products. The company is a pioneer in the use of stable isotopes in gastroenterology, cardiovascular and inborn metabolic diseases. Helicobacter Test INFAI (HTI) is approved in centralized procedure by EMA first time in all European countries since 1997 and available for routine diagnosis of Helicobacter pylori infection. In the meantime, HTI is registered as medicinal product (medical prescription) in more than 40 countries worldwide.
INFAI's laboratories in Bochum, Germany and in York, England are equipped with state-of-the-art IRMS mass spectrometer and 600 MHz NMR spectrometer which is used to investigate metabolic disorders, cardiovascular diseases and a number of other diseases. These facilities are used for internal research and product development, but are also available for collaborative and contract research. In last 10 years, a range of non-invasive, highly efficient breath tests using stable isotopes has been developed. Gastromotal (13C octanoic acid gastric emptying test) and Pancreo-Lip (13C mixed triglyceride exocrine pancreatic function test) are in preparation for approval by EMA but now available for clinical studies. INFAI is associated with a number of companies in several European countries and outside the Europe. All other developed products of INFAI you can find on our website: https://www.infai1.com
Since 1997, INFAI GmbH has been supporting the European Helicobacter & Microbiota Study Group (EHMSG) as Gold Sponsor.
Belgian Helicobacter and Microbiota Study Group (BHMSG)
Juvisé Pharmaceuticals is a French pharmaceutical company founded by Frédéric Mascha in 2008 serving 4 million patients worldwide. With a particular focus on gastroenterology, oncology, and cardiac pathology, Juvisé is a key partner for healthcare professionals. Through its 10 specialties marketed in 80 countries, mainly in Europe, Africa and Middle East, the mission of Juvisé is to improve access to care for patients, placing the eradication of H. pylori for infected patient as its top priorities. Click to read more: https://juvisepharmaceuticals.com/
In 2016 Mayoly Spindler acquired Kibion – the world leader in fast and reliable urea breath testing machines and tests for the diagnosis and eradication control of Helicobacter pylori for the diagnosis and control of the eradication of this bacterium.
In 2019 Mayoly Spindler created the new business unit Mayoly Diagnostic.
As a strategic pillar of the development of our company this business unit is dedicated to the marketing of analytical systems, consumables and drugs for the diagnosis and eradication control of Helicobacter pylori.
Metagenics Belgium BV
Metagenics, producer and distributor of high-grade micronutrition, is a global group with sites in the US, Australia, New Zealand, Europe & Canada, and dealers in dozens of countries.
As an international group, we make ourselves stronger by pooling our knowledge, scientific insights, and experience in various markets.
This global exchange secures Metagenics a leading role in the high-grade micronutrition sector, wanting to help people live healthier, happier lives by developing high-grade micronutrition underpinned by science.
Please visit the Website
EHMSG gratefully acknowledges a grant from the UEG
United European Gastroenterology (UEG) is Europe’s home and umbrella for multidisciplinary gastroenterology and unites over 50,000 engaged professionals from national and specialist societies, individual digestive health experts, and related scientists from all fields and career stages. As the leading non-profit organisation for excellence in digestive health, UEG improves the prevention and care of digestive diseases in Europe through providing top tier education, supporting research, and advancing clinical standards. The myUEG Community enables digestive health professionals from across the globe to become myUEG Associates and thereby connect, network and benefit from a wide range of free resources and educational activities.
EHMSG gratefully acknowledges a grant from the Flemish Government
The multidisciplinary UEG Week and Postgraduate Teaching (PGT) are the premier venues for researchers from across the globe to present their latest findings.
Scientific programme: Top-tier multidisciplinary science awaits! In every session, delegates have the opportunity to interact in real-time via our Q&A tool both in-person and virtually. Access the online programme here: https://ueg.eu/week/programme
Registration is open March 30 to October 17, 2023. Attractive registration packages to participate onsite in Copenhagen or online: https://ueg.eu/week/attendance
Join the multidisciplinary and multinational myUEG community in Copenhagen or online!